View this email in your browser for a better experience.
Register TODAY!

Treatment of Behavioral Variant Frontotemporal Degeneration

April 13, 2023, 4-5 p.m. ET

Join Dr. Simon Ducharme, a neuropsychiatrist, researcher, and expert specializing in FTD, as he presents on the treatment of behavioral variant FTD (bvFTD). This webinar is designed specifically for primary care physicians, neurologists, psychiatrists, geriatricians and other clinical specialists.

Dr. Ducharme will discuss treatment considerations for bvFTD symptoms as well as non-pharmacological approaches for disease management. This includes an overview of pharmacological treatments for common behavioral symptoms such as apathy, agitation, anxiety, and obsessive-compulsive behaviors, as well as the lack of evidence for approved Alzheimer’s treatments in FTD.

He will also highlight the importance of education of family members about best practices for communication and environmental adaptations to respond to behavioral challenges. The program will close with a review of current research related to symptomatic bvFTD treatment.

Upon completion of this activity, learners will be able to:
  • List two treatments that can be effective with bvFTD symptoms.
  • Recognize the potential adverse reactions to psychotropic medications in FTD.
  • Describe the value of non-pharmacological interventions for a person with bvFTD and their family caregivers.

Free CME or CEU available!

Content for this AFTD Educational Webinar is targeted to physicians, nurses, psychologists, and social workers. This webinar will be recorded and archived on AFTD’s YouTube page. (NOTE: Continuing credit ONLY available for live viewing.)

Please forward this email or download a flyer to share with your colleagues!
Register TODAY!
Simon Ducharme, MD is a neuropsychiatrist and a clinician-scientist at the Douglas Mental Health University Institute and the Montreal Neurological Institute. He is specialized in frontotemporal dementia and the interface between psychiatric disorders and dementia. His research program uses advanced neuroimaging techniques and other tools to develop diagnostic biomarkers for FTD. He is in charge of several innovative clinical trials on dementia and is the author of over 115 scientific articles and seven book chapters. Dr. Ducharme is the director of the McGill Division of Geriatric Psychiatry & Neuropsychiatry and the director of the American Neuropsychiatric Association committee on research.
Accreditation Statement:
In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

For Medicine:
Rush University Medical Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For Nursing:
Rush University Medical Center designates this live activity for a maximum of 1.00 nursing contact hour(s).

For Psychologists:
Rush University Medical Center designates this live activity for 1.00 CE credits in psychology.

For Social Work:
As a Jointly Accredited Organization, Rush University Medical Center is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved continuing education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.

Financial Disclosures:
Individuals in control of content for this activity have the following relevant relationships to disclose and all relevant financial relationships have been mitigated. All planners, editors, faculty and reviewers of this activity have no relevant financial relationships to disclose. This presentation was created without any commercial support.
Share this event Share this event
Tweet about it Tweet about it
Post on LinkedIn Post on LinkedIn
Manage which AFTD emails you'd like to receive:
Manage Your Email Preferences:
Forward This Email  |  Update Your Subscription  |  Unsubscribe
Like Us
Follow Us
See Us
Join Us
Copyright ©2023 AFTD. All rights reserved.

The Association for Frontotemporal Degeneration
2700 Horizon Drive, Suite 120, King of Prussia, PA 19406